N/A Completed N=31 Health Services Research

Coaching for HCV and HIV

Hepatitis C · HIV · Opioid Use Disorder

Source: ClinicalTrials.gov NCT04314414 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2022

Primary outcomePrimary: Acceptability of Intervention — 13; 6; 0; 0 Participants

Summary

The objective of this study is to determine the feasibility and acceptability of a peer recovery coach (PRC) intervention to improve linkage to hepatitis C (HCV) and/or human immunodeficiency virus (HIV) care, treatment initiation, and evaluation for HIV pre-exposure prophylaxis (PrEP) (when applicable) among individuals with a history of opioid use disorder accessing a substance use low-barrier-to-access (LBA) walk-in clinic. In-depth interviews will be administered to participants at baseline, three- and six-months for study participants (40 total participants). The investigator will also follow-up with the per recovery coach and administer surveys to assess the feasibility of a peer recovery coaching intervention in improving HCV/HIV related linkage to care and management. Patient medical records and peer recovery coach monthly reports will be accessed and reviewed to determine fidelity to research protocols.

Outcome Measures

Outcome	Result	p-value
PRIMARY Acceptability of Intervention	13; 6; 0; 0; 1; 16	—
SECONDARY Participant Linkage to HIV Care	9; 5; 2; 0; 0; 12	—
SECONDARY Participant Linkage to HCV Care	0; 2	—
SECONDARY Participant Linkage to Care for Opioid Use	10; 6; 0; 0; 0; 15	—
SECONDARY Number of Participants Who Received Pre-exposure Prophylaxis (PrEP)	5; 6	—
SECONDARY Number of Participants Who Received HCV Care	0; 2	—
SECONDARY Number of Participants Who Received Opioid Use Treatment	22; 6; 15; 13	—

Eligibility Criteria

Inclusion Criteria

Individuals with opioid use disorder, non-reactive HIV antibody test and reactive HCV antibody testing at the BMC LBA walk-in clinic
Able to speak English
Individuals providing contact information of two family members or friends
Individuals signing a medical records release form

Exclusion Criteria

Individuals already linked to substance use care
Individuals co-infected with HIV and HCV and engaged in care

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04314414). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.